TTM
79.4%
YoY change
+0.57pp
Trough year (2013)
74.5%
Peak year (1995)
218.5%
Latest annual
78.8%
Gross Margin history chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: 78.8%
Gross Margin change chart for Gilead Sciences (GILD) from 1990 to 2025
Latest: +0.57pp
Gross Margin history table for Gilead Sciences (GILD) from 1990 to 2025
| 2025 | 78.8% | +0.57pp | ||
| 2024 | 78.3% | +2.22pp | ||
| 2023 | 76.0% | -3.23pp | ||
| 2022 | 79.3% | +3.44pp | ||
| 2021 | 75.8% | -5.66pp | ||
| 2020 | 81.5% | +2.31pp | ||
| 2019 | 79.2% | +1.11pp | ||
| 2018 | 78.1% | -5.19pp | ||
| 2017 | 83.3% | -2.72pp | ||
| 2016 | 86.0% | -1.75pp | ||
| 2015 | 87.7% | +2.95pp | ||
| 2014 | 84.8% | +10.30pp | ||
| 2013 | 74.5% | -0.05pp | ||
| 2012 | 74.5% | -0.13pp | ||
| 2011 | 74.7% | -1.81pp | ||
| 2010 | 76.5% | -0.77pp | ||
| 2009 | 77.2% | -1.63pp | ||
| 2008 | 78.9% | -2.95pp | ||
| 2007 | 81.8% | -3.85pp | ||
| 2006 | 85.7% | -1.49pp | ||
| 2005 | 87.2% | -0.26pp | ||
| 2004 | 87.4% | +0.41pp | ||
| 2003 | 87.0% | +1.95pp | ||
| 2002 | 85.1% | +3.78pp | ||
| 2001 | 81.3% | -1.58pp | ||
| 2000 | 82.9% | -7.14pp | ||
| 1999 | 90.0% | -3.25pp | ||
| 1998 | 93.2% | -1.91pp | ||
| 1997 | 95.2% | -15.62pp | ||
| 1996 | 110.8% | -107.74pp | ||
| 1995 | 218.5% | +38.93pp | ||
| 1994 | 179.6% | — | ||
| 1992 | 140.5% | +4.76pp | ||
| 1991 | 135.7% | -25.82pp | ||
| 1990 | 161.5% | — |
- 202578.8%+0.57pp
- 202478.3%+2.22pp
- 202376.0%-3.23pp
- 202279.3%+3.44pp
- 202175.8%-5.66pp
- 202081.5%+2.31pp
- 201979.2%+1.11pp
- 201878.1%-5.19pp
- 201783.3%-2.72pp
- 201686.0%-1.75pp
- 201587.7%+2.95pp
- 201484.8%+10.30pp
- 201374.5%-0.05pp
- 201274.5%-0.13pp
- 201174.7%-1.81pp
- 201076.5%-0.77pp
- 200977.2%-1.63pp
- 200878.9%-2.95pp
- 200781.8%-3.85pp
- 200685.7%-1.49pp
- 200587.2%-0.26pp
- 200487.4%+0.41pp
- 200387.0%+1.95pp
- 200285.1%+3.78pp
- 200181.3%-1.58pp
- 200082.9%-7.14pp
- 199990.0%-3.25pp
- 199893.2%-1.91pp
- 199795.2%-15.62pp
- 1996110.8%-107.74pp
- 1995218.5%+38.93pp
- 1994179.6%—
- 1992140.5%+4.76pp
- 1991135.7%-25.82pp
- 1990161.5%—
Gross Margin values are taken from Gilead Sciences's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Margin at Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's latest reported gross margin is 79.4%. Gross margin is gross profit divided by revenue, expressed as a percentage. It shows how much of each sales dollar survives the direct cost of goods sold — before operating expenses, interest, and taxes. A higher gross margin generally signals pricing power and production efficiency. Margins are most meaningful compared against sector peers and a company's own history.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Gilead Sciences (GILD) gross margin totalled 78.83% – expanded 0.6 percentage points year-over-year.
The record annual gross margin stands at 218.52%, reached in 1995; the historical low of 74.48% was recorded in 2013.
Gilead Sciences Gross Margin by Year
Gilead Sciences Gross Margin 2025: 78.8%
In 2025, Gilead Sciences reported gross margin of 78.83%, expanded 0.6 percentage points from 2024.
Gilead Sciences Gross Margin 2024: 78.3%
Gilead Sciences gross margin in 2024 was 78.26%, expanded 2.2 percentage points from 2023.
Gilead Sciences Gross Margin 2023: 76.0%
2023's gross margin for Gilead Sciences came in at 76.04%, contracted 3.2 percentage points from 2022.
Gilead Sciences Gross Margin 2022: 79.3%
Gilead Sciences posted gross margin of 79.26% in 2022, expanded 3.4 percentage points from 2021.
Gilead Sciences Gross Margin 2021: 75.8%
Gilead Sciences gross margin in 2021 was 75.82%.
See more financial history for Gilead Sciences (GILD).
Sector peers by Gross Margin
Healthcare peers of Gilead Sciences (GILD), ranked by their latest gross margin
| 83.5% | |
| 81.8% | |
| 81.7% | |
| 75.9% | |
| 71.5% | |
| 70.7% | |
| 70.0% | |
| 18.8% |
- 83.5%
- 81.8%
- 81.7%
- 75.9%
- 71.5%
- 70.7%
Frequently asked questions
Gilead Sciences (GILD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation